IP Library Granted Patent US 8,236,939
Granted Patent B2
US 8,236,939 · App. 12/800,556 · Granted Aug 7, 2012

Micrornas and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,236,939
App. No.
12/800,556
Granted
Aug 7, 2012
Kind
B2
Abstract

Described herein are polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.

Claims (7)

1. An isolated nucleic acid selected from the group consisting of:

(a) SEQ ID NO: 4;

(b) a RNA encoded by the nucleic acid of (a), wherein the RNA is identical in length to (a);

(c) a sequence at least 80% identical to (a) or (b); and

(d) the complement of (a), (b) or (c), wherein the complement is identical in length to the nucleic acid of (a), (b), or (c).

2. A vector comprising a heterologous sequence, wherein the heterologous sequence consists of the sequence of the nucleic acid of claim 1 .

3. A probe comprising a heterologous sequence, wherein the heterologous sequence consists of the sequence of the nucleic acid of claim 1 .

Assignments (1)
SECURITY INTEREST Recorded Dec 15, 2017
From: ROSETTA GENOMICS INC.; ROSETTA GENOMICS LTD; MINUET DIAGNOSTICS, INC.; CYNOGEN INC.
To: GENOPTIX, INC.
Reel/Frame 044899/0237 →